Association of T916C (Y257H) mutation in Candida albicans ERG11 with fluconazole resistance

Mycoses

Volumn 56, Issue 3, 2013, Pages 315-320

  Zhao, Jie ^a,b   Xu, Yonghao ^a   Li, Chunyang ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Candida albicans; Drug resistance; Fluconazole; Lanosterol 14a demethylase

Indexed keywords

FLUCONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DNA SEQUENCE; ERG11 GENE; FUNGAL GENE; GENE EXPRESSION; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; SITE DIRECTED MUTAGENESIS;

CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; GENES, FUNGAL; GENETIC VECTORS; HOMOLOGOUS RECOMBINATION; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, SITE-DIRECTED; MUTATION; SACCHAROMYCES CEREVISIAE; TRANSFORMATION, GENETIC;

CANDIDA ALBICANS; SACCHAROMYCES CEREVISIAE;

EID: 84876324014     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12027     Document Type: Article

References (26)

1. Manastir L, Ergon MC, Yucesoy M. Investigation of mutations in Erg11 gene of fluconazole resistant Candida albicans isolates from Turkish hospitals. Mycoses 2011; 54: 99-104.
2. Alvarez-Rueda N, Fleury A, Morio F et al. Amino acid substitutions at the major insertion loop of Candida albicans sterol 14alpha-demethylase are involved in fluconazole resistance. PLoS ONE 2011; 6: e21239.
3. Xu Y, Chen L, Li C. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations. J Antimicrob Chemother 2008; 61: 798-804.
4. Lamb DC, Kelly DE, White TC et al. The R467K amino acid substitution in Candida albicans sterol 14α-demethylase causes drug resistance through reduced affinity. Antimicrob Agents Chemother 2000; 44: 63-7.
5. Lamb DC, Kelly DE, Schunck WH et al. The mutation T315A in Candida albicans sterol 14alpha-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity. J Biol Chem 1997; 272: 5682-8.
6. Li D, Gurkovska V, Sheridan M et al. Studies on the regulation of the two-component histidine kinase gene CHK1 in Candida albicans using the heterologous lacZ reporter gene. Microbiology 2004; 150: 3305-13.
7. Wickner RB. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 1994; 264: 566-9.
8. Schaub Y, Dunkler A, Walther A et al. New pFA-cassettes for PCR-based gene manipulation in Candida albicans. J Basic Microbiol 2006; 46: 416-29.
9. Yu JH, Hamari Z, Han KH et al. Double-joint PCR: a PCR-based molecular tool for gene manipulations in filamentous fungi. Fungal Genet Biol 2004; 41: 973-81.
10. Gietz RD, Schiestl RH. High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc 2007; 2: 31-4.
11. Chen LM, Xu YH, Zhou CL et al. Overexpression of CDR1 and CDR2 genes plays an important role in fluconazole resistance in Candida albicans with G487T and T916C mutations. J Int Med Res 2010; 38: 536-45.
12. -ΔΔCT Method. Methods 2001; 25: 402-8.
13. Franz R, Kelly SL, Lamb DC et al. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 1998; 42: 3065-72.
14. White TC, Holleman S, Dy F et al. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002; 46: 1704-13.
15. Andes D, Nett J, Oschel P et al. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 2004; 72: 6023-31.
16. Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000; 46: 397-403.
17. Martel CM, Parker JE, Bader O et al. Identification and characterization of four azole-resistant erg3 mutants of Candida albicans. Antimicrob Agents Chemother 2010; 54: 4527-33.
18. Morio F, Pagniez F, Lacroix C et al. Amino acid substitutions in the Candida albicans sterol {Delta}5, 6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence. J Antimicrob Chemother 2012; 67: 2131-8.
19. Morio F, Loge C, Besse B et al. Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. Diagn Microbiol Infect Dis 2010; 66: 373-84.
20. Feng LJ, Wan Z, Wang XH et al. Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene. Chin Med J (Engl) 2010; 123: 544-8.
21. Chau AS, Mendrick CA, Sabatelli FJ et al. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles. Antimicrob Agents Chemother 2004; 48: 2124-31.
22. Xiao L, Madison V, Chau AS et al. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob Agents Chemother 2004; 48: 568-74.
23. Jiang W, Tan S, Jiang G. Synergistic effect of terbinafine combined with fluconazole or itraconazole on stable fluconazole-resistant Candida albicans induced by fluconazole in vitro. Chin J Microbiol Immunol 2006; 26: 360-4.
24. Sheng C, Zhang W, Zhang M et al. Homology modeling of lanosterol 14alpha-demethylase of Candida albicans and Aspergillus fumigatus and insights into the enzyme-substrate Interactions. J Biomol Struct Dyn 2004; 22: 91-9.
25. Kakeya H, Miyazaki Y, Miyazaki H et al. Genetic analysis of azole resistance in the Darlington strain of Candida albicans. Antimicrob Agents Chemother 2000; 44: 2985-90.
26. Sanglard D, Ischer F, Koymans L et al. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 1998; 42: 241-53.